Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
002412 Hunan Hansen Pharmaceutical
- 6.36
- +0.10+1.60%
Market Closed Dec 20 15:00 CST
3.20BMarket Cap14.16P/E (TTM)
6.42High6.25Low81.61KlotVolume6.26Open6.26Pre Close51.57MTurnover1.64%Turnover Ratio15.63P/E (Static)503.20MShares7.0752wk High1.52P/B3.17BFloat Cap4.0852wk Low6.89Limit Up497.85MShs Float23.15Historical High5.63Limit Down2.72%Amplitude3.36Historical Low--Dividend TTM6.32Avg Price35.96KlotAsk--Div YieldTTM100Lot Size45.44KlotBid
Hunan Hansen Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.44%693.98M | 1.86%480.45M | 1.54%254.03M | 4.31%955.53M | 0.44%684.14M | 1.94%471.67M | 0.53%250.18M | 2.72%916.06M | 3.22%681.15M | 4.42%462.68M |
| Operating revenue | 1.44%693.98M | 1.86%480.45M | 1.54%254.03M | 4.31%955.53M | 0.44%684.14M | 1.94%471.67M | 0.53%250.18M | 2.72%916.06M | 3.22%681.15M | 4.42%462.68M |
| Other operating revenue | ---- | -57.22%519.74K | ---- | -57.09%1.58M | ---- | 633.61%1.22M | ---- | 144.73%3.68M | ---- | -54.56%165.62K |
| Total operating cost | -9.90%554.72M | -8.47%379.98M | -4.42%193.72M | -0.20%784.24M | -1.05%615.7M | 2.53%415.12M | 1.37%202.68M | 1.85%785.79M | 4.77%622.26M | 2.08%404.88M |
| Operating cost | -8.15%172.56M | -8.97%121.99M | -10.30%65.45M | -0.00%255.89M | -1.85%187.86M | 4.86%134.02M | 8.38%72.96M | 4.09%255.9M | 5.43%191.4M | 5.32%127.81M |
| Operating tax surcharges | 2.22%13.96M | 1.70%9.58M | 9.95%5.21M | 5.18%18.91M | 2.01%13.66M | 4.35%9.42M | -2.10%4.73M | 0.20%17.98M | -0.05%13.39M | -2.77%9.03M |
| Operating expense | -15.11%294.41M | -11.56%200.76M | 0.70%102.55M | -0.34%394.68M | 1.97%346.82M | 5.18%227.01M | -3.53%101.85M | -1.30%396.03M | 4.36%340.13M | -1.04%215.84M |
| Administration expense | 28.01%45.12M | 23.86%27.6M | 20.11%12.21M | 5.53%68.36M | -16.31%35.25M | -19.18%22.28M | -19.54%10.17M | 6.44%64.77M | -1.26%42.11M | 0.10%27.56M |
| Financial expense | -39.16%1.21M | -25.71%918.16K | -38.07%410.74K | -39.95%1.92M | -10.02%1.99M | -22.43%1.24M | -25.44%663.19K | -48.12%3.2M | -45.25%2.21M | -37.48%1.59M |
| -Interest expense (Financial expense) | -30.79%2.02M | -22.32%1.49M | -10.05%901.8K | -5.78%3.68M | 2.21%2.92M | -1.36%1.92M | 1.93%1M | -40.12%3.91M | -43.39%2.86M | -37.02%1.95M |
| -Interest Income (Financial expense) | 2.98%-1.08M | 8.06%-770.52K | -40.20%-520.2K | -115.68%-1.97M | -35.08%-1.12M | -67.39%-838.09K | -90.21%-371.05K | -33.06%-914.66K | 25.25%-826.03K | 18.89%-500.69K |
| Research and development | -8.86%27.45M | -9.57%19.13M | -35.92%7.89M | -7.14%44.48M | -8.74%30.12M | -8.18%21.16M | 41.74%12.31M | 21.42%47.9M | 25.32%33.01M | 29.52%23.04M |
| Credit Impairment Loss | -11,723.49%-1.71M | -17,986.45%-1.79M | -119.90%-20.72K | -11,755.32%-3.28M | -83.65%14.74K | -88.91%9.99K | 23.81%104.1K | -107.98%-27.71K | -79.19%90.19K | -79.13%90.09K |
| Asset Impairment Loss | 93.81%-6.63K | 110.10%9.87K | 131.44%24.31K | 99.09%-372.96K | 42.75%-107.25K | -20.24%-97.75K | 9.91%-77.31K | 1.39%-40.87M | 52.59%-187.35K | 75.88%-81.3K |
| Other net revenue | -78.45%10.46M | -64.79%15.34M | -49.42%7.69M | 8.78%63.65M | -37.38%48.52M | 37.46%43.57M | 39.17%15.21M | 95.28%58.51M | 37.20%77.49M | -5.00%31.69M |
| Fair value change income | 8.97%1.4M | -10.27%807.99K | -37.32%369.16K | 59.47%1.8M | 52.80%1.28M | 67.67%900.47K | 685.28%588.96K | 180.80%1.13M | --838.98K | --537.04K |
| Invest income | -89.25%4.74M | -70.91%11.81M | -64.87%4.59M | -33.23%61.15M | -37.55%44.1M | 51.54%40.6M | 27.73%13.06M | 34.88%91.58M | 29.70%70.63M | -15.74%26.79M |
| -Including: Investment income associates | -93.22%2.79M | -72.60%10.53M | -67.47%4M | -36.21%57.75M | -41.58%41.1M | 44.18%38.45M | 20.95%12.29M | 35.44%90.53M | 29.21%70.36M | -16.14%26.67M |
| Asset deal income | ---- | ---- | ---- | ---15.43K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other revenue | 86.94%6.04M | 108.72%4.5M | 77.64%2.73M | -34.72%4.38M | -47.21%3.23M | -50.54%2.15M | 142.29%1.54M | 142.80%6.71M | 208.05%6.12M | 196.29%4.36M |
| Operating profit | 28.00%149.72M | 15.67%115.81M | 8.45%68.01M | 24.44%234.94M | -14.24%116.96M | 11.87%100.12M | 4.79%62.71M | 25.63%188.79M | 11.34%136.38M | 12.10%89.5M |
| Add:Non operating Income | -6.78%452.52K | -8.82%322.5K | -57.69%33.72K | 16.24%625.38K | 12.41%485.41K | 100.77%353.71K | 15.08%79.69K | 63.73%537.99K | 77.90%431.84K | -15.94%176.18K |
| Less:Non operating expense | 69.60%612.26K | -19.16%262.33K | 5,817.59%107.15K | 27.68%9.55M | -50.67%361K | -34.77%324.5K | -99.21%1.81K | 968.95%7.48M | 145.31%731.77K | 267.69%497.44K |
| Total profit | 27.73%149.56M | 15.70%115.87M | 8.20%67.94M | 24.29%226.02M | -13.96%117.09M | 12.30%100.15M | 5.20%62.79M | 21.32%181.85M | 11.14%136.08M | 11.59%89.18M |
| Less:Income tax cost | 155.93%18.8M | 62.16%15.37M | 25.25%9.67M | 47.52%21M | 22.26%7.35M | -7.91%9.48M | -1.76%7.72M | -5.41%14.24M | -32.83%6.01M | 10.98%10.29M |
| Net profit | 19.15%130.75M | 10.84%100.49M | 5.81%58.26M | 22.31%205.01M | -15.63%109.74M | 14.94%90.67M | 6.26%55.07M | 24.30%167.62M | 14.61%130.07M | 11.67%78.88M |
| Net profit from continuing operation | 19.15%130.75M | 10.84%100.49M | 5.81%58.26M | 22.31%205.01M | -15.63%109.74M | 14.94%90.67M | 6.26%55.07M | 24.30%167.62M | 14.61%130.07M | 11.67%78.88M |
| Net profit of parent company owners | 19.15%130.75M | 10.84%100.49M | 5.81%58.26M | 22.31%205.01M | -15.63%109.74M | 14.94%90.67M | 6.26%55.07M | 24.30%167.62M | 14.61%130.07M | 11.67%78.88M |
| Earning per share | ||||||||||
| Basic earning per share | 19.12%0.2598 | 10.82%0.1997 | 5.85%0.1158 | 22.31%0.4074 | -15.63%0.2181 | 14.92%0.1802 | 6.21%0.1094 | 24.29%0.3331 | 14.63%0.2585 | 11.68%0.1568 |
| Diluted earning per share | 19.12%0.2598 | 10.82%0.1997 | 5.85%0.1158 | 22.31%0.4074 | -15.63%0.2181 | 14.92%0.1802 | 6.21%0.1094 | 24.29%0.3331 | 14.63%0.2585 | 11.68%0.1568 |
| Other composite income | -33.58%7.49M | 22.67%14.07M | 9.70%6.13M | 186.66%14.84M | 689.61%11.28M | 710.20%11.47M | 311.92%5.59M | -589.96%-17.13M | -124.51%-1.91M | 269.63%1.42M |
| Other composite income of parent company owners | -33.58%7.49M | 22.67%14.07M | 9.70%6.13M | 186.66%14.84M | 689.61%11.28M | 710.20%11.47M | 311.92%5.59M | -589.96%-17.13M | -124.51%-1.91M | 269.63%1.42M |
| Total composite income | 14.23%138.24M | 12.17%114.56M | 6.17%64.4M | 46.10%219.86M | -5.57%121.02M | 27.20%102.14M | 23.33%60.66M | 8.78%150.49M | 5.66%128.16M | 15.04%80.3M |
| Total composite income of parent company owners | 14.23%138.24M | 12.17%114.56M | 6.17%64.4M | 46.10%219.86M | -5.57%121.02M | 27.20%102.14M | 23.33%60.66M | 8.78%150.49M | 5.66%128.16M | 15.04%80.3M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
